Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome : randomised double blind clinical trial . To compare the effectiveness of clomifene citrate plus metformin and clomifene citrate plus placebo in women with newly diagnosed polycystic ovary syndrome . Randomised clinical trial . Multicentre trial in 20 Dutch hospitals . 228 women with polycystic ovary syndrome . Clomifene citrate plus metformin or clomifene citrate plus placebo . The primary outcome measure was ovulation . Secondary outcome measures were ongoing pregnancy , spontaneous abortion , and clomifene resistance . 111 women were allocated to clomifene citrate plus metformin ( metformin group ) and 114 women were allocated to clomifene citrate plus placebo ( placebo group ) . The ovulation rate in the metformin group was 64 % compared with 72 % in the placebo group , a non - significant difference ( risk difference - 8 % , 95 % confidence interval - 20 % to 4 % ) . There were no significant differences in either rate of ongoing pregnancy ( 40 % v 46 % ; - 6 % , - 20 % to 7 % ) or rate of spontaneous abortion ( 12 % v 11 % ; 1 % , - 7 % to 10 % ) . A significantly larger proportion of women in the metformin group discontinued treatment because of side effects ( 16 % v 5 % ; 11 % , 5 % to 16 % ) . Metformin is not an effective addition to clomifene citrate as the primary method of inducing ovulation in women with polycystic ovary syndrome . Current Controlled Trials ISRCTN55906981 [ controlled - trials .com ] .